Rob Abrams, Chief Executive Officer and Operating Partner, Sanderling Ventures

Rob Abrams' Bio

Michael Siani-Rose, President and Founder, has 15 years of biotechnology experience. He has extensive experience in the computational chemistry and drug discovery fields, including managerial and scientific positions at Protos/Chiron Corporation, Kosan Biosciences and Affymetrix. Michael has published 35 peer-reviewed articles, is inventor on five patents in the field of drug discovery/drug design, and has a dozen patent applications in the fields of bioinformatics and tissue engineering.

Gary D. Gentzkow, M.D., Chief Medical Officer, was trained in Internal Medicine. For the past 18 years his research has focused on cardiovascular and critical care medicine, in addition to burns and wound healing, first with growth factors and then bioengineered human tissue. He served as Medical Director for Advanced Tissue Sciences where he was responsible for the clinical development of Dermagraft and Transcyte, which are now FDA-approved human tissues for chronic wounds and burns, respectively. Gary received an A.B. Cum Laude from Harvard University and an M.D. from University of Oregon Health Sciences Center.

Gilbert R. Mintz, Ph.D., Chief Business Officer, brings 23 years of experience in the biotechnology industry to Theregen. His experience includes 15 years in business development and licensing activities. Gilbert has provided strategic planning, business development and transactional expertise to several public and pre-IPO companies. In addition, he has executed several in/out licensing agreements of therapeutic products for partnerships in the U.S., Europe and Japan. Gilbert received a B.S. Cum Laude in chemistry from University of Pittsburgh, Pennsylvania and a Ph.D. in Biochemistry from Washington University, St. Louis, Missouri.

Gianine M. Figliozzi, Director of Operations, brings over 15 years of experience in biotechnology and drug discovery to our laboratory facilities in San Diego, Calif. Gianine has a B.S. degree in Chemistry from the University of California, Berkeley. She has held R&D positions at Liposome Technology Inc., Chiron Corporation and Discovery Partners International. Her professional experience spans pharmaceutical development from early stage drug discovery research to process development and manufacture of clinical material under GMP conditions.